v3.26.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Jun. 30, 2026
Current assets:    
Cash and cash equivalents $ 68,267 $ 67,711
Prepaid expenses and other assets 693 537
Research and development (“R&D”) tax incentive receivable 1,272 4,579
Total current assets 70,232 72,827
Property, plant and equipment, net 2 4
Investment in joint venture 77 51
Operating lease right-of-use assets 83 97
Total assets 70,394 72,979
Current liabilities:    
Trade and other payables 944 1,158
Accrued expenses and other current liabilities 30 272
Operating lease liabilities, current 62 62
Total current liabilities 1,036 1,492
Operating lease liabilities, non-current 21 34
Warrant Liabilities 3,200 4,080
Total liabilities 4,257 5,606
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock, $0.0001 par value – shares 800,000,000 authorized; 12,544,607 and 12,544,298 shares issued and outstanding at September 30, 2026 and June 30, 2026, respectively 38 38
Additional paid-in capital 248,081 247,769
Accumulated deficit (178,796) (176,858)
Foreign currency translation reserve (3,186) (3,576)
Total stockholders’ equity 66,137 67,373
Total liabilities and stockholders’ equity $ 70,394 $ 72,979